Delivery Order SPE2DB22D2206-SPE2DB24FHG71

Award Date 5/20/24
Potential Completion Date 5/21/24
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $10,906.75, is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,525.20, is a Delivery Order for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product, with a completion date of December 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,211.30 firm fixed-price delivery order is for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,105.65 firm fixed-price delivery order contract is for 4566307024 ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of November 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, as well as a separate $750,000...
This federal contract award, valued at $4,559.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the pharmaceutical product ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, with an ultimate completion date of May 24, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the federal government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,580.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract provides for the delivery of the pharmaceutical product "ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML" to support the DLA's medical supply requirements. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,371.00 firm fixed price delivery order contract is for the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $3,072.49, is a delivery order for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,549.06 Firm Fixed Price Delivery Order is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of October 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, valued at $4,611.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and it covers the procurement of the pharmaceutical product ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. The award has an ultimate completion date of February 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FHG71
    Delivery Order

This federal contract award, valued at $4,741.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4564653296 ! ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML. The contract has a completion date of May 21, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

The contract award is not associated with a set-aside designation, indicating that it was awarded on a full and open competition basis. Amerisourcebergen's expertise in pharmaceutical distribution and its extensive supply chain network have made the company a competitive supplier of critical medical products to various federal agencies, including the DoD and VA healthcare systems.

Generated 8/25/24, 12:21 AM